Veeva Systems Cl A saw its IBD SmartSelect Composite Rating rise to 97 Thursday, up from 94 the day before.
The new rating is a sign the stock is outpacing 97% of all stocks when it comes to the most important stock-picking criteria. The top-performing stocks tend to have a 95 or better grade as they launch a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Veeva Systems Cl A is currently forming a consolidation, with a 258.93 entry. Look for the stock to break out in volume at least 40% higher than normal.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The stock sports a 98 EPS Rating, which means its recent quarterly and annual earnings growth is outpacing 98% of all stocks.
Its Accumulation/Distribution Rating of C- shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
The company reported a 31% earnings-per-share gain for Q3. Revenue growth fell to 13%, down from 15% in the previous quarter. The company's next quarterly report is expected on or around Mar. 5.
Veeva Systems Cl A earns the No. 3 rank among its peers in the Computer Software-Medical industry group. Doximity is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
